Welcome

Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Investor Home

Investor Presentation

BioLife Solutions Investor Presentation October 2024

Recent Events

BioLife Solutions, Inc. Q3 2024 Earnings Conference Call and Business Update

Tuesday, November 12, 2024

1:30pm - 2:30pm PST

Latest News

Get News Alerts by Email

Jan 13, 2025

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations

Fourth quarter Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the high end of previously raised...

Dec 16, 2024

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the...

View All News and Press Releases